Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Agenda & Minutes France Typhoid Ebola Human papillomavirus (HPV)
Download:
NITAG recommendation Recommendation United States of America Diphtheria Tetanus Pertussis
Download:
Efficacy/effectiveness Administration Newborn (0-1 years) Children (2-9 years) Tuberculosis Diphtheria Tetanus Pertussis Measles
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Rotavirus
Economic aspects Newborn (0-1 years) Children (2-9 years) Rotavirus